Cogent Biosciences, Inc. SEC filings COGT

Cogent Biosciences, Inc. has 616 filings in SEC EDGAR's recent list, going back to Oct 20, 2014. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
10-K Annual report Feb 17, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
10-K Annual report Feb 25, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
10-K Annual report Feb 26, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 25, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K Annual report Mar 16, 2021 Dec 31, 2020
10-K Annual report Mar 26, 2020 Dec 31, 2019
10-K Annual report Mar 28, 2019 Dec 31, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
COGT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
Large accelerated filer
SEC CIK
1622229
Former names
Unum Therapeutics Inc. (until Oct 5, 2020); Unum Therapeutics, Inc. (until Mar 30, 2018)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.